446 related articles for article (PubMed ID: 19088106)
1. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.
Xu H; Lui WT; Chu CY; Ng PS; Wang CC; Rogers MS
Hum Reprod; 2009 Mar; 24(3):608-18. PubMed ID: 19088106
[TBL] [Abstract][Full Text] [Related]
2. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
Xu H; Becker CM; Lui WT; Chu CY; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wai Man GC; Wang CC
Fertil Steril; 2011 Oct; 96(4):1021-8. PubMed ID: 21821246
[TBL] [Abstract][Full Text] [Related]
3. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.
Laschke MW; Schwender C; Scheuer C; Vollmar B; Menger MD
Hum Reprod; 2008 Oct; 23(10):2308-18. PubMed ID: 18603648
[TBL] [Abstract][Full Text] [Related]
5. Natural therapies assessment for the treatment of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
[TBL] [Abstract][Full Text] [Related]
6. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.
Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M
Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human endostatin on endometriosis in mice.
Jiang HQ; Li YL; Zou J
Chin Med J (Engl); 2007 Jul; 120(14):1241-6. PubMed ID: 17697575
[TBL] [Abstract][Full Text] [Related]
8. [Study of tissue morphology and vascular endothelial growth factor and matrix metalloproteinase-9 gene expressions in nude mouse endometriosis model].
Wang DB; Zhang SL; Niu HY; Lu JM
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):759-62. PubMed ID: 15634503
[TBL] [Abstract][Full Text] [Related]
9. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice.
Ozawa Y; Murakami T; Tamura M; Terada Y; Yaegashi N; Okamura K
Fertil Steril; 2006 Oct; 86(4 Suppl):1146-51. PubMed ID: 16962108
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M
Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861
[TBL] [Abstract][Full Text] [Related]
11. [Expression of vascular endothelial growth factor receptors in the ectopic and eutopic endometrium of women with endometriosis].
Wang HB; Lang JH; Leng JH; Zhu L; Liu ZF; Sun DW
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1555-9. PubMed ID: 16179118
[TBL] [Abstract][Full Text] [Related]
12. Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Meresman GF; Barañao RI
Reprod Sci; 2011 Jul; 18(7):614-22. PubMed ID: 21266664
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
Rudzitis-Auth J; Menger MD; Laschke MW
Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
[TBL] [Abstract][Full Text] [Related]
14. [The chick embryo chorioallantioc membrane as a model for in vivo research on anti-angiogenesis in endometriosis].
Wang HB; Leng JH; Zhu L; Liu ZF; Sun DW; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):43-7. PubMed ID: 17331421
[TBL] [Abstract][Full Text] [Related]
15. ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model.
Wang Y; Lin M; Weng H; Wang X; Yang L; Liu F
Am J Obstet Gynecol; 2014 Jun; 210(6):531.e1-8. PubMed ID: 24495669
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.
Laschke MW; Elitzsch A; Vollmar B; Vajkoczy P; Menger MD
Hum Reprod; 2006 Jan; 21(1):262-8. PubMed ID: 16172144
[TBL] [Abstract][Full Text] [Related]
17. Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model.
Vlahos NF; Gregoriou O; Deliveliotou A; Perrea D; Vlachos A; Zhao Y; Lai J; Creatsas G
Fertil Steril; 2010 Mar; 93(4):1316-23. PubMed ID: 19147132
[TBL] [Abstract][Full Text] [Related]
18. A priori implantation potential does not differ in eutopic endometrium of patients with and without endometriosis.
Gescher DM; Siggelkow W; Meyhoefer-Malik A; Malik E
Arch Gynecol Obstet; 2005 Jul; 272(2):117-23. PubMed ID: 15986219
[TBL] [Abstract][Full Text] [Related]
19. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
Novella-Maestre E; Carda C; Noguera I; Ruiz-Saurí A; García-Velasco JA; Simón C; Pellicer A
Hum Reprod; 2009 May; 24(5):1025-35. PubMed ID: 19189995
[TBL] [Abstract][Full Text] [Related]
20. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A
Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
